Recombinant DNA News and Research

RSS
Recombinant DNA is a variety of techniques that molecular biologists use to manipulate DNA molecules to study the expression of a gene.
Fox Chase Cancer Center announces first-in-human bi-specific HER2/HER3 pathway targeting antibody

Fox Chase Cancer Center announces first-in-human bi-specific HER2/HER3 pathway targeting antibody

Naturxan expands production and distribution capabilities to provide worldwide availability of Aquasta

Naturxan expands production and distribution capabilities to provide worldwide availability of Aquasta

Vect-Horus accentuates its leadership in delivering drugs to the central nervous system

Vect-Horus accentuates its leadership in delivering drugs to the central nervous system

Study results from US Military Malaria Vaccine Program announced

Study results from US Military Malaria Vaccine Program announced

News outlets examine H1N1's impact on U.S. vaccine development plans, Mexico's handling of outbreak

News outlets examine H1N1's impact on U.S. vaccine development plans, Mexico's handling of outbreak

EUREKA project develops unique range of antibodies

EUREKA project develops unique range of antibodies

Bayer HealthCare Pharmaceuticals' RECOTHROM solution receives Health Canada approval

Bayer HealthCare Pharmaceuticals' RECOTHROM solution receives Health Canada approval

GeoVax Labs presents results of preclinical study on prototype HIV/AIDS vaccine at CROI

GeoVax Labs presents results of preclinical study on prototype HIV/AIDS vaccine at CROI

Soligenix' LPM oral drug delivery technology receives Hong Kong patent

Soligenix' LPM oral drug delivery technology receives Hong Kong patent

GeoVax Labs provides updates on HIV-1 vaccine trials

GeoVax Labs provides updates on HIV-1 vaccine trials

Cequent Pharmaceuticals' IND application for CEQ508 approved for clinical trial

Cequent Pharmaceuticals' IND application for CEQ508 approved for clinical trial

Eli Lilly provides financial guidance for 2010

Eli Lilly provides financial guidance for 2010

Scarab Genomics reduces the E. coli K-12 genome, optimizing it for recombinant DNA and protein production

Scarab Genomics reduces the E. coli K-12 genome, optimizing it for recombinant DNA and protein production

NCKU transfers microalgal docosahexaenoic acid production technology to Vedan Biotechnology

NCKU transfers microalgal docosahexaenoic acid production technology to Vedan Biotechnology

Professor Suzanne Cory receives award for her work in cancer and immunogenetics

Professor Suzanne Cory receives award for her work in cancer and immunogenetics

Researchers make breakthrough in finding a vaccine against horse disease strangle

Researchers make breakthrough in finding a vaccine against horse disease strangle

The still elusive malaria vaccine

The still elusive malaria vaccine

Scarab Genomics releases new E. Coli strain

Scarab Genomics releases new E. Coli strain

Partial success reported in the Phase 3 trial of HIV/AIDS vaccine

Partial success reported in the Phase 3 trial of HIV/AIDS vaccine

Sunlight Research's report analyzes Amgen EPO US patent portfolio

Sunlight Research's report analyzes Amgen EPO US patent portfolio